Theratechnologies Inc T.TH

U.S.

[Bucknelly21]

Maybe the u.s. just doesn't like Thtx. This is pathetic

[qwerty22]

Seems true of the majority of Canadian biotechs, there are exceptions though. I was hoping Paul came with a US network of contacts, maybe even Leah had built something to tap into. Doesn't seem much evidence of that though.  

[SPCEO1]

On the regulatory front, the US has been kinder to TH than Europe. TH has always been able to get things through the FDA, if only narrowly. But the EMA shot down Egrifta for lipo even after the FDA had approved it and now they are apparently not willing to go along with the NASH phase III. I suspect having Dr. Loomba on our team really helped get the pahse III across the finish line with the FDA

[scarlet1967]

Where is the updated IP, oncology still preclinical, why not feed/encourage folks like liver lady to write frequent articles explaining the company's prospects on well followed seeking alpha, why not preparing a convincing presentation post it on drbeen with over 200 k followers on YouTube, how the heck can US and the rest of the world would get it when they only attend few conferences with

[Bucknelly21]

Last heard she was going to do a write up when they got the ph3 approval